de la Puente, P., B. Muz, A. Jin, F. Azab, M. Luderer, N. N. Salama, and A. K. Azab,
"MEK inhibitor, TAK-733 reduces proliferation, affects cell cycle and apoptosis, and synergizes with other targeted therapies in multiple myeloma.",
Blood cancer journal, vol. 6, pp. e399, 2016 Feb 26.
de la Puente, P., N. Quan, R. S. Hoo, B. Muz, R. C. Gilson, M. Luderer, J. King, S. Achilefu, N. N. Salama, R. Vij, et al.,
"Newly established myeloma-derived stromal cell line MSP-1 supports multiple myeloma proliferation, migration, and adhesion and induces drug resistance more than normal-derived stroma.",
Haematologica, vol. 101, issue 7, pp. e307-11, 2016 Jul.
H, S., Z. AR, M. E, A. A. SA, A. OS, B. AA, L. MM, A. R, and M. S,
Peripheral vein infusion of autologous mesenchymal stem cells in Egyptian HCV-positive patients with end-stage liver disease,
, cairo, stem cells, 2014.